0001144204-19-016966.txt : 20190329 0001144204-19-016966.hdr.sgml : 20190329 20190329154750 ACCESSION NUMBER: 0001144204-19-016966 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190304 FILED AS OF DATE: 20190329 DATE AS OF CHANGE: 20190329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chan Phillip P. CENTRAL INDEX KEY: 0001442786 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36792 FILM NUMBER: 19716255 MAIL ADDRESS: STREET 1: 1001 BRIGGS ROAD STREET 2: SUITE 280 CITY: MOUNT LAUREL STATE: NJ ZIP: 08054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cytosorbents Corp CENTRAL INDEX KEY: 0001175151 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980373793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 DEER PARK DRIVE, SUITE K CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 BUSINESS PHONE: 973-329-8885 MAIL ADDRESS: STREET 1: 7 DEER PARK DRIVE, SUITE K CITY: MONMOUTH JUNCTION STATE: NJ ZIP: 08852 FORMER COMPANY: FORMER CONFORMED NAME: MedaSorb Technologies CORP DATE OF NAME CHANGE: 20060807 FORMER COMPANY: FORMER CONFORMED NAME: GILDER ENTERPRISES INC DATE OF NAME CHANGE: 20020611 4/A 1 tv517552_4a.xml OWNERSHIP DOCUMENT X0306 4/A 2019-03-04 2019-03-06 0 0001175151 Cytosorbents Corp CTSO 0001442786 Chan Phillip P. C/O CYTOSORBENTS CORPORATION 7 DEER PARK DRIVE, SUITE K MONMOUTH JUNCTION NJ 08852 1 1 0 0 President and CEO Common Stock 2019-03-04 4 A 0 5500 0 A 496383 D These shares represent restricted stock units ("RSUs") which shall vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting. Includes (i) the following RSUs that will be settled into common stock upon vesting upon a "Change In Control," as defined in the 2014 Long-Term Incentive Plan: (a) 10,300 RSUs granted on March 15, 2018, (b) 18,700 RSUs granted on February 24, 2017, (c) 57,000 RSUs granted on June 7, 2016 and (d) 130,000 RSUs granted on April 8, 2015, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 14,334 RSUs granted on February 28, 2018 which are unvested as of the date hereof and (b) 5,500 RSUs granted on March 4, 2019, reported on this Form 4 and (iii) 260,549 shares of common stock owned by the reporting person. This amended Form 4 corrects an error in Table I, Item 5 and the corresponding footnote (2) reflected on the original Form 4 filed on March 6, 2019. The original Form 4 misreported the number of shares held by the reporting person following offset for taxes. /s/ Kathleen P. Bloch, attorney-in-fact For Phillip P. Chan 2019-03-29